Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.

Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat

• Publication year

  1991

• Venue

  British Journal of Cancer

• Publication date

  1991-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/bjc.1991.128PMID 1827030PMCID 1972366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour cell resistance to anthracyclines — A review

  2004cited by this paper
• The pharmacokinetics of polymer-bound adriamycin.

  1990cited by this paper
• Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone.

  1989cited by this paper
• Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo

  1989cited by this paper
• Correlation between growth inhibition and intranuclear doxorubicin and 4'-deoxy-4'-iododoxorubicin quantitated in living K562 cells by microspectrofluorometry.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model.

  1989cited by this paper
• Adriamycin-induced lipid peroxidation in mitochondria and microsomes.

  1988cited by this paper
• Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

  1988cited by this paper
• Adriamycin-induced leakage of lysosomal enzymes in vitro

  1988cited by this paper
• Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV.

  1987cited by this paper
• Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.

  1987cited by this paper
• Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.

  1986cited by this paper
• Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives.

  1986cited by this paper
• Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugates☆

  1985cited by this paper
• Cellular pharmacology of detorubicin and doxorubicin in L1210 cells.

  1984cited by this paper
• Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues.

  1983cited by this paper
• Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system.

  1981cited by this paper
• Preparation and biological properties of a covalent antitumor drug—arm—carrier (DAC conjugate)

  1980cited by this paper
• Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

  1978cited by this paper
• Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts.

  1978cited by this paper
• Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

  1978cited by this paper
• Simple and rapid fluorimetric method for DNA microassay.

  1977cited by this paper
• Commentary. Lysosomotropic agents.

  1974cited by this paper
• Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.

  1972cited by this paper
• Chemotherapy through lysosomes with a DNA-daunorubicin complex.

  1972cited by this paper
• Preparation and properties of plasma membrane and endoplasmic reticulum fragments from isolated rat fat cells.

  1971cited by this paper
• Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase.

  1961cited by this paper
• The fluorometric measurement of pyridine nucleotides.

  1957cited by this paper
• Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

  1955cited by this paper

• Drug Formulations: How these Affects Anticancer Drug

  2014cites this paper
• CRITICAL REVIEW IN PHARMACEUTICAL SCIENCES

  2014cites this paper
• Review Article BIODEGRADABLE POLYMERS: A SMART STRATEGY FOR TODAY'S CRUCIAL NEEDS

  2014cites this paper
• Polymers and drug delivery systems.

  2012cites this paper
• Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.

  2012cites this paper
• Nanomedicine(s) under the microscope.

  2011cites this paper
• Carbohydrate-based Biomedical Copolymers for Targeted Delivery of Anticancer Drugs

  2010cites this paper
• HPMA copolymers: origins, early developments, present, and future.

  2010cites this paper
• Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.

  2009cites this paper
• The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug delivery.

  2008cites this paper
• Synthesis and biological characterisation of HPMA copolymer-mannose conjugates designed for intracellular delivery of anti-leishmanial compounds to macrophages.

  2008cites this paper
• Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imaging

  2007cites this paper
• Pharmacokinetics of Nanocarrier-Mediated Drug and Gene Delivery

  2006cites this paper
• Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer–doxorubicin

  2006cites this paper
• HPMA based macromolecular therapeutics: Internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition

  2006cites this paper
• Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.

  2005cites this paper
• N-(2-Hydroxypropyl) methacrylamide Copolymer

  2005cites this paper
• Drug targeting with nano-sized carrier systems

  2005cites this paper
• Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.

  2003cites this paper
• Differences in the intracellular fate of free and polymer-bound doxorubicin.

  2002cites this paper
• Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus.

  2002cites this paper
• Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.

  2002cites this paper
• Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells.

  2001cites this paper
• N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.

  2001cites this paper
• Receptor-mediated targeted drug or toxin delivery.

  1998cites this paper
• Macromolecular Systems for Chemotherapy and Magnetic Resonance Imaging.

  1996cites this paper
• Biodegradable polymers for protein and peptide drug delivery.

  1995cites this paper
• Polymer conjugates with anticancer activity

  1995cites this paper
• Arabinogalactan for hepatic drug delivery.

  1994cites this paper
• Polymer Conjugates

  1994cites this paper
• Soluble polymers for lectin-mediated drug targeting

  1994cites this paper
• Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studies.

  1993cites this paper
• Development of N-(2-hydroxypropyl)methacrylamide copolymer conjugates for delivery of cancer chemotherapy

  1993cites this paper
• Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.

  1993cites this paper
• Passive tumor targeting of soluble macromolecules and drug conjugates.

  1992cites this paper
• Drug-polymer conjugates: potential for improved chemotherapy.

  1992cites this paper
• Preclinical evaluation of polymer-bound doxorubicin

  1992cites this paper